OIA
CRNX icon

OneDigital Investment Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

OneDigital Investment Advisors’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253K Buy
6,774
+415
+7% +$15.4K ﹤0.01% 1387
2026
Q1 		$231K Buy
6,359
+1,737
+38% +$77.6K ﹤0.01% 1332
2025
Q4 		$215K Buy
+4,622
New +$206K ﹤0.01% 1405

Other funds holding CRNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

OneDigital Investment Advisors's CRNX Position: Q2 2026 in Review

OneDigital Investment Advisors increased its Crinetics Pharmaceuticals (CRNX) stake by 6.5% in Q2 2026, buying an estimated $15.4K and bringing the position to 6,774 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

OneDigital Investment Advisors first reported a position in CRNX in Q4 2025 and has held it in 3 quarters since. 149 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • OneDigital Investment Advisors held 6,774 shares of Crinetics Pharmaceuticals worth $253K as of Q2 2026.
  • OneDigital Investment Advisors bought 415 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $15.4K.
  • Crinetics Pharmaceuticals made up ﹤0.01% of OneDigital Investment Advisors's portfolio in Q2 2026, its #1387 holding.
  • OneDigital Investment Advisors first reported a position in Crinetics Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 149 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on OneDigital Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.